Clough Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$15.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$11.9M |
| 3 |
TSMC
TSM
|
+$11.7M |
| 4 |
Wynn Resorts
WYNN
|
+$10.1M |
| 5 |
Northrop Grumman
NOC
|
+$9.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$17.9M |
| 2 |
Starwood Property Trust
STWD
|
+$13.1M |
| 3 |
HDFC Bank
HDB
|
+$13.1M |
| 4 |
ICICI Bank
IBN
|
+$12.9M |
| 5 |
Texas Instruments
TXN
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.46% |
| 2 | Technology | 13.61% |
| 3 | Industrials | 12.55% |
| 4 | Financials | 10.76% |
| 5 | Consumer Discretionary | 8.93% |
Similar funds
Clough Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Clough Capital Partners held 191 positions worth $928M, down 5.9% from $986M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Clough Capital Partners withdrew a net $78.8M in Q1 2023, closing 27 positions and reducing 51 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $17.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Clough Capital Partners opened a new position in Illumina worth $16.8M.
- Clough Capital Partners's largest Q1 2023 buy was Illumina: 74,335 shares worth $16.8M.
- Clough Capital Partners added most to Johnson & Johnson in Q1 2023, an estimated $11.9M increase.
- Clough Capital Partners's biggest Q1 2023 reduction was Starwood Property Trust, cutting an estimated $13.1M.
- Clough Capital Partners fully exited State Street SPDR S&P Biotech ETF in Q1 2023, selling an estimated $17.9M.
- Clough Capital Partners's ten largest holdings make up 25% of its $928M portfolio in Q1 2023.
- Clough Capital Partners opened 35 new positions and closed 27 in Q1 2023.
- Clough Capital Partners's portfolio value fell 5.9% quarter-over-quarter to $928M.
Based on Clough Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.